AstraZeneca

astrazeneca.com · Cambridge, United Kingdom

AstraZeneca is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes prescription medicines, with a primary focus on oncology, cardiovascular, renal and metabolism, and respiratory and immunology diseases. It serves healthcare providers, hospitals, and governments worldwide, generating revenue through the sale of branded pharmaceuticals and biologic therapies. The company also engages in research collaborations and licensing agreements with other life sciences organizations.

Revenue
$45.7B
Employees
83,000
Founded
1999
Headquarters
Cambridge, United Kingdom

What 12 Arbolus experts think of AstraZeneca

NPS scores are predominantly high, with 72% at NPS 8 or above and 36% at NPS 10. Renewal intent is affirmative among those who reported, with all indicating continued adoption. Over 85% of respondents are in post-implementation stages (>1 year), reinforcing high product stickiness and satisfaction. The quantitative data highlights consistent satisfaction, with no mention of negative sentiment. Overall Customer Sentiment: Positive

Who reviewed AstraZeneca

Total customers 12 11 current · 1 former
Reviews growth +9 in six months
Seniority of respondents
  • C-Suite 56% (7)
  • Director 44% (5)
Not specified Director NPS 10
Other Generalist C-Suite NPS 10 Will renew
Other Analyst Not specified NPS 9

Employer names and spend open once the report publishes.

Tell us when the AstraZeneca report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

50 Net Promoter Score, from 12 scored reviews
  • Promoters 6
  • Passives 6
  • Detractors 0

Cumulative NPS by month

+0 over 6 months
  • Feb 9
  • Mar 8
  • May 8
  • Jun 9
  • Jul 8
  • Aug 9

Net Promoter Score across 2 reviews, accumulated up to each month. Category median 51 across 2 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 100%
  • Will renew 4
  • Undecided 0
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 100% 2 answers
  • Director 100% 2 answers
  • 8.5/10 Average score from customers who will renew

Top alternatives

Most weighed by AstraZeneca customers

For people who use AstraZeneca

Do you use AstraZeneca at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 12 customers of AstraZeneca have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.